Table 3.
Associations between body composition measures and clinical outcomes.
| At diagnosis | After 3 years | After 5 years | |||||||
|---|---|---|---|---|---|---|---|---|---|
| SMI < 48.6 cm2/m2 (n = 46) | SMI ≥ 48.6 cm2/m2 (n = 39) | P | SMI < 48.6 cm2/m2 (n = 65) | SMI ≥ 48.6 cm2/m2 (n = 20) | P | SMI < 48.6 cm2/m2 (n = 62) | SMI ≥ 48.6 cm2/m2 (n = 23) | P | |
| Death | 6 (13.0) | 0 (0.0) | 0.019 | 5 (7.7) | 1 (5.0) | 0.681 | 3 (4.8) | 3 (13.0) | 0.190 |
| Recurrence | 6 (13.0) | 4 (10.3) | 0.691 | 7 (10.8) | 3 (15.0) | 0.608 | 7 (11.3) | 3 (13.0) | 0.824 |
| Grade 4 Neutropenia | 16 (34.8) | 4 (10.3) | 0.008 | 18 (27.7) | 2 (10.0) | 0.103 | 17 (27.4) | 3 (13.0) | 0.165 |
| SAT < 226.6 cm2 (n = 54) | SAT ≥ 226.6 cm2 (n = 31) | P | SAT < 226.6 cm2 (n = 51) | SAT ≥ 226.6 cm2 (n = 34) | P | SAT < 226.6 cm2 (n = 56) | SAT ≥ 226.6 cm2 (n = 29) | P | |
|---|---|---|---|---|---|---|---|---|---|
| Death | 6 (11.1) | 0 (0.0) | 0.054 | 4 (7.8) | 2 (5.9) | 0.730 | 5 (8.9) | 1 (3.4) | 0.349 |
| Recurrence | 8 (14.8) | 2 (6.5) | 0.249 | 7 (13.7) | 3 (8.8) | 0.492 | 9 (16.1) | 1 (3.4) | 0.087 |
| Grade 4 Neutropenia | 13 (24.1) | 7 (22.6) | 0.876 | 11 (21.6) | 9 (26.5) | 0.602 | 12 (21.4) | 8 (27.6) | 0.526 |
| VAT < 45.5 cm2 (n = 19) | VAT ≥ 45.5 cm2 (n = 66) | P | VAT < 45.5 cm2 (n = 20) | VAT ≥ 45.5 cm2 (n = 65) | P | VAT < 45.5 cm2 (n = 18) | VAT ≥ 45.5 cm2 (n = 67) | P | |
|---|---|---|---|---|---|---|---|---|---|
| Death | 3 (15.8) | 3 (4.5) | 0.092 | 2 (10.0) | 4 (6.2) | 0.557 | 2 (11.1) | 4 (6.0) | 0.450 |
| Recurrence | 2 (10.5) | 8 (12.1) | 0.849 | 3 (15.0) | 7 (10.8) | 0.608 | 4 (22.2) | 6 (9.0) | 0.121 |
| Grade 4 Neutropenia | 5 (26.3) | 15 (22.7) | 0.745 | 5 (25.0) | 15 (23.1) | 0.859 | 4 (22.2) | 16 (23.9) | 0.883 |
Data are expressed as the number of patients with percentages in parentheses.
SMI skeletal muscle index, SAT subcutaneous adipose tissue area, VAT visceral adipose tissue area.